LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $82,032 | -53.2% | 8,699 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $175,111 | -99.9% | 8,699 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $253,749,000 | +39.6% | 8,699 | +42.5% | 0.00% | +33.3% |
| Q1 2018 | $181,807,000 | +92658.7% | 6,105 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $196,000 | -54.7% | 6,105 | -50.9% | 0.00% | 0.0% |
| Q3 2017 | $433,000 | +17.0% | 12,444 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $370,000 | +30.3% | 12,444 | +30.8% | 0.00% | +50.0% |
| Q1 2017 | $284,000 | +70.1% | 9,512 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $167,000 | -47.3% | 9,512 | -28.7% | 0.00% | -50.0% |
| Q3 2016 | $317,000 | +48.8% | 13,341 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $213,000 | -23.7% | 13,341 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $279,000 | +17.2% | 13,341 | +51.3% | 0.00% | 0.0% |
| Q4 2015 | $238,000 | -2.9% | 8,820 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $245,000 | +13.4% | 8,820 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $216,000 | – | 8,820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,018,000 | 94.79% |
| TANG CAPITAL MANAGEMENT LLC | 9,405,490 | $39,879,000 | 11.22% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,870,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,777,000 | 0.13% |
| FIRST MIDWEST BANK TRUST DIVISION | 89,341 | $379,000 | 0.05% |
| WealthTrust Axiom LLC | 30,400 | $128,000 | 0.04% |
| PREMIER ASSET MANAGEMENT LLC | 51,305 | $217,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 18,113 | $77,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 39,000 | $165,000 | 0.02% |
| Inscription Capital, LLC | 10,000 | $42,000 | 0.01% |